BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 16476906)

  • 1. Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial.
    Scheiman MM; Hertle RW; Kraker RT; Beck RW; Birch EE; Felius J; Holmes JM; Kundart J; Morrison DG; Repka MX; Tamkins SM;
    Arch Ophthalmol; 2008 Dec; 126(12):1634-42. PubMed ID: 19064841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of adding a plano lens to atropine for amblyopia.
    ; Wallace DK; Lazar EL; Repka MX; Holmes JM; Kraker RT; Hoover DL; Weise KK; Waters AL; Rice ML; Peters RJ
    J AAPOS; 2015 Feb; 19(1):42-8. PubMed ID: 25727586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atropine vs Patching-Reply.
    Repka MX; Kraker RT; Holmes JM;
    JAMA Ophthalmol; 2015 May; 133(5):619-20. PubMed ID: 25695639
    [No Abstract]   [Full Text] [Related]  

  • 4. Amblyopia therapy.
    Fleck BW
    Br J Ophthalmol; 2003 Mar; 87(3):255-6. PubMed ID: 12598430
    [No Abstract]   [Full Text] [Related]  

  • 5. Stability of visual acuity improvement following discontinuation of amblyopia treatment in children aged 7 to 12 years.
    Hertle RW; Scheiman MM; Beck RW; Chandler DL; Bacal DA; Birch E; Chu RH; Holmes JM; Klimek DL; Lee KA; Repka MX; Weakley DR;
    Arch Ophthalmol; 2007 May; 125(5):655-9. PubMed ID: 17502505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast sensitivity following amblyopia treatment in children.
    Repka MX; Kraker RT; Beck RW; Cotter SA; Holmes JM; Arnold RW; Astle WF; Sala NA; Tien DR;
    Arch Ophthalmol; 2009 Sep; 127(9):1225-7. PubMed ID: 19752439
    [No Abstract]   [Full Text] [Related]  

  • 7. Compliance and patching and atropine amblyopia treatments.
    Wang J
    Vision Res; 2015 Sep; 114():31-40. PubMed ID: 25743080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of amblyopia: current practice and emerging trends.
    Papageorgiou E; Asproudis I; Maconachie G; Tsironi EE; Gottlob I
    Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1061-1078. PubMed ID: 30706134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contradictions in the amblyopia treatment studies.
    Lempert P
    Arch Ophthalmol; 2006 Feb; 124(2):285; author reply 285-7. PubMed ID: 16476906
    [No Abstract]   [Full Text] [Related]  

  • 10. Amblyopia in children aged 7 to 17 years.
    Phillips CI
    Arch Ophthalmol; 2006 Nov; 124(11):1668; author reply 1668-9. PubMed ID: 17102030
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential bias in amblyopia treatment study.
    Lempert P
    Arch Ophthalmol; 2009 Mar; 127(3):348; author reply 349. PubMed ID: 19273812
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized trial to evaluate combined patching and atropine for residual amblyopia.
    ; Wallace DK; Kraker RT; Beck RW; Cotter SA; Davis PL; Holmes JM; Repka MX; Suh DW
    Arch Ophthalmol; 2011 Jul; 129(7):960-2. PubMed ID: 21746992
    [No Abstract]   [Full Text] [Related]  

  • 13. Concern about the Pediatric Eye Disease Investigator Group 2-year follow-up study.
    Kushner BJ
    Arch Ophthalmol; 2005 Nov; 123(11):1615-6. PubMed ID: 16286633
    [No Abstract]   [Full Text] [Related]  

  • 14. Atropine vs patching for treatment of moderate amblyopia: follow-up at 15 years of age of a randomized clinical trial.
    Repka MX; Kraker RT; Holmes JM; Summers AI; Glaser SR; Barnhardt CN; Tien DR;
    JAMA Ophthalmol; 2014 Jul; 132(7):799-805. PubMed ID: 24789375
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.